harmonybiosciences.com (HRMY) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Maxsus dori vositalarining yetkazib berish xavfsizligi bevosita iste'molchiga qadar qat'iy transport nazorati orqali kafolatlanadi. Harmony Biosciences (HRMY) yuqori rahbariyatining strategik kursi istiqbolli aktivlarni sotib olish orqali mahsulotlar liniyasini kengaytirishga tayanadi. GURU.Markets platformasidagi Harmony Biosciences (HRMY) narxlar dinamikasi, bu yerda ko'rsatkich 0.14 ga teng, patentlar va noyob miya patologiyalari terapiyasi segmentidagi eksklyuzivlik maqomi bilan himoyalangan biznesning barqarorligini tasdiqlaydi.
&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_HRMY_-_Harmony-Biosciences_-_Long-Term-Debt-to-Equity-Ratio "HRMY - Harmony Biosciences Holdings, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 31.10.2026 oraligʻida | 👁️GURU.Markets👁️")
Harmony Biosciences (HRMY) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Harmony Biosciences|HRMY - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati harmonybiosciences.com|HRMY - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Harmony Biosciences Holdings, Inc.|HRMY - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari Harmony Biosciences|Tezkor likvidlik ko‘rsatkichi harmonybiosciences.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning jamlanma tahlili:HRMY, Harmony Biosciences Inc
Ushbu koeffitsiyent uzoq muddatli majburiyatlarning kapitalga nisbatini o'lchaydi, bu esa investorlarga moliyalashtirish tuzilmasining barqarorligini va haddan tashqari yuqori kredit yuklamasi xavfini baholash imkonini beradi. Harmony Biosciences (HRMY) uchun uzoq muddatli qarzlarning kapitalga nisbati tarixi qarz kapitali va Wakix dori vositasining kengayishiga kiritilgan investitsiyalar o'rtasidagi muvozanatni namoyish etadi, bu esa kompaniyaning to'lovga qobiliyatsizlik xavfisiz sotuvlarni kengaytirish bo'yicha fundamental imkoniyatlarini belgilaydi.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|BHVN: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati AMLX|Uzoq muddatli qarzning kapitalga nisbati Trevi Therapeutics Inc (TRVI)|Uzoq muddatli qarzning o'z kapitaliga nisbati Praxis Medicines PRAX|Uzoq muddatli qarzning kapitalga koeffitsiyenti AVXL|CBLL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Prothena Corporation PLC (PRTA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|alector.com (ALEC) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Annexon Biosciences (ANNX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Omeros Corp|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi NGNE (Neurogene Therapeutics)|Uzoq muddatli qarzning o'z kapitaliga nisbati ACIU (AC Immune)|VYGR - Uzoq muddatli majburiyatlarning kapitalga nisbati|Neumora Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti SCLX|Tevogen Bio Holdings, Inc. - Uzoq muddatli qarzning kapitalga nisbati|ACOG: Uzoq muddatli qarzning o'z kapitaliga nisbati|CGTX: Uzoq muddatli qarzning kapitalga nisbati|IKT - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Cassava Sciences|Uzoq muddatli majburiyatlarning kapitalga nisbati Assertio Therapeutics ASRT|Uzoq muddatli qarzning o'z kapitaliga nisbati Coya Therapeutics, Inc. (COYA)|Uzoq muddatli qarzdorlikning kapitalga nisbati vistagen.com|Uzoq muddatli qarzning kapitalga nisbati OVID (Ovid Therapeutics)|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|CervoMed - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Alterity Therapeutics ATHE|CLNN: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati PepGen (PEPG)|Uzoq muddatli qarzning o'z kapitaliga nisbati Jupiter Neurosciences Inc|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi RLMD (relmada.com)|Uzoq muddatli qarzning kapitalga nisbati ANVS|Uzoq muddatli qarzning o'z kapitaliga nisbati gracetx.com GRCE|Uzoq muddatli qarzning kapitalga nisbati AIFF (Firefly Neuroscience Inc)|ANEW Medical (KLTO) - Uzoq muddatli majburiyatlarning kapitalga nisbati|NRSN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati revivapharma.com RVPH|MTVA: Uzoq muddatli qarzning kapitalga nisbati|NeurAxis Inc. - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|PASG: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Neuphoria Therapeutics Inc. (NEUP)|Uzoq muddatli qarzning o'z kapitaliga nisbati minervaneurosciences.com NERV|Athira Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Addex Therapeutics Ltd. (ADXN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ALZN - Uzoq muddatli qarzning o'z kapitaliga nisbati|CYCN (Cyclerion Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|PTIX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Pasithea Therapeutics Corp. (KTTA)|Uzoq muddatli qarzning o'z kapitaliga nisbati CRGT|Uzoq muddatli qarzning kapitalga nisbati Avenue Therapeutics Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|CARA (Cara Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics CHRO|Eliem Therapeutics, Inc. (ELYM) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Intra-Cellular - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti LBPH (Longboard Pharmaceuticals Inc)|MRNS: Uzoq muddatli qarzning kapitalga nisbati|NKGen Biotech Corp (NKGN) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|SAGE: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevena Inc. TRVN|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical Inc. (WENA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CERE - Uzoq muddatli qarzning o'z kapitaliga nisbati